We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Primary Rituximab and Maintenance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00140582
Recruitment Status : Completed
First Posted : September 1, 2005
Last Update Posted : March 13, 2017
HOVON - Dutch Haemato-Oncology Association
German Low Grade Lymphoma Study Group (GLSG/OSHO)
Australasian Leukaemia and Lymphoma Group
Institute of Cancer Research, United Kingdom
Information provided by (Responsible Party):
Lymphoma Study Association

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2007
  Study Completion Date : December 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):